Analysis of clinical patient-specific pre-treatment quality assurance with the new helical tomotherapy platform, following the AAPM TG-218 report

Analysis of clinical patient-specific pre-treatment quality assurance with the new helical tomotherapy platform, following the AAPM TG-218 report

Abstract Purpose This study presents patient-specific quality assurance (QA) results from the first 395 clinical cases for the new helical TomoTherapy® platform (Radixact) coupled with dedicated Precision TPS. Methods The passing rate of the Gamma Index (GP%) of 395 helical QA of patient-specific to...

Full description

Bibliographic Details
Main Authors: Marco Fusella, Samuele Cavinato, Alessandra Germani, Marta Paiusco, Nicola Pivato, Marco Andrea Rossato, Anthony Scott, Alessandro Scaggion
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Radiation Oncology
Subjects:
TomoTherapy
Quality assurance
Pre-treatment quality assurance
IMRT QA
Online Access:https://doi.org/10.1186/s13014-021-01952-w

Internet

https://doi.org/10.1186/s13014-021-01952-w

Similar Items